Voltar
Artigo Acesso aberto Revisado por pares
BIBTEX RIS

High-dose versus standard dose twice-daily thoracic radiotherapy in limited stage small-cell lung cancer: final survival data, long-term toxicity and relapse patterns in a randomised, open-label, phase II trial

2025; Elsevier BV; Linguagem: Inglês

10.1016/j.jtho.2025.04.007

ISSN

1556-1380

Autores

Bjørn Henning Grønberg, Kristin Toftaker Killingberg, Øystein Fløtten, Maria Moksnes Bjaanæs, Odd Terje Brustugun, Tesfaye Madebo, Seppo W. Langer, Signe Lenora Risumlund, Tine Schytte, Nina Helbekkmo, Kirill Neumann, Øyvind Yksnøy, Jens Engleson, Sverre Fluge, Thor Naustdal, Liv Giske, Jan Nyman, Georgios Tsakonas, Tarje Onsøien Halvorsen,

Tópico(s)

Lung Cancer Treatments and Mutations

Referência(s)